ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,162, issued on Dec. 9, was assigned to ITERION THERAPEUTICS INC. (Houston).
"Formulations of tegavivint" was invented by Gowri Sukumar (Spring, Texas) and Drazen Ostovic (Redwood City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations."
The patent was filed on April 22, 2024, under Application No. 18/642,595.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&...